Brain natriuretic peptide as a cardiac hormone in essential hypertension.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  American Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(92)90011-YPMID 1530996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension.

  1992cited by this paper
• Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells.

  1991cited by this paper
• Human brain natriuretic peptide, a novel cardiac hormone.

  1990cited by this paper
• Rat brain natriuretic peptide--tissue distribution and molecular form.

  1990cited by this paper
• Isolation and sequence determination of human brain natriuretic peptide in human atrium

  1990cited by this paper
• Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells.

  1990cited by this paper
• Human brain natriuretic peptide, a novel cardiac hormone

  1990influential reference
• Brain natriuretic peptide is a novel cardiac hormone.

  1989cited by this paper
• Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases

  1989cited by this paper
• Brain natriuretic peptide interacts with atrial natriuretic peptide receptor in cultured rat vascular smooth muscle cells

  1988cited by this paper
• The presence of brain natriuretic peptide of 12,000 daltons in porcine heart.

  1988cited by this paper
• A new natriuretic peptide in porcine brain

  1988cited by this paper
• Circulating atrial natriuretic peptides in hyperthyroidism and hypothyroidism.

  1987cited by this paper
• Circulating atrial natriuretic polypeptide in essential hypertension.

  1987cited by this paper
• Plasma alpha natriuretic peptide in cardiac impairment.

  1986cited by this paper
• Raised circulating levels of atrial natriuretic peptides in essential hypertension.

  1986cited by this paper
• Plasma concentration of atrial natriuretic polypeptide in essential hypertension.

  1985cited by this paper
• Alpha-human atrial natriuretic polypeptide is released from the heart and circulates in the body.

  1985cited by this paper
• Some Statistical Methods Useful in Circulation Research

  1980cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper
• Arterial hypertension. Report of a WHO expert committee.

  1978cited by this paper
• Measurement of Left Ventricular Wall Thickness and Mass by Echocardiography

  1972cited by this paper
• HORMONES AND LACTATION.

  1964cited by this paper
• Perspex specimen-boxes.

  1947cited by this paper

• Natriuretic peptides and cardiac troponins in hypertension and heart failure: A contemporary review of the evidence.

  2026cites this paper
• NT-proBNP Levels in Relation to Various Grades of Hypertension – An Observational Study

  2023cites this paper
• Inverse Regulation of Serum Osteoprotegerin and B-Type Natriuretic Peptide Concentrations by Free Fatty Acids Elevation in Young Healthy Humans

  2022cites this paper
• Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure.

  2020cites this paper
• Natriuretic peptides and neprilysin inhibition in hypertension and hypertensive organ damage.

  2020cites this paper
• Premature atrial and ventricular complexes in outpatients referred from a primary care facility

  2018cites this paper
• Association of N-Terminal Pro B-Type Natriuretic Peptide With Blood Pressure and Pulse Pressure in Elderly People　- A Cross-Sectional Population Study.

  2018cites this paper
• Platelet-derived miR-142-3p induces apoptosis of endothelial cells in hypertension.

  2017cites this paper
• B-type natriuretic peptide and renovascular hypertension; is there any relation?

  2017cites this paper
• Cyclic nucleotide regulation of cardiac sympatho‐vagal responsiveness

  2016cites this paper
• Suppression of Resting Metabolism by the Angiotensin AT2 Receptor.

  2016cites this paper
• Novel Chemiluminescent Enzyme Immunoassays for Individual Quantification of 3 Endogenous Molecular Forms of Atrial Natriuretic Peptide in Human Plasma.

  2016cites this paper
• Characteristics and outcomes of acute heart failure in sub Saharan Africa

  2016cites this paper
• Tissue-specific roles for the renin-angiotensin system in cardiovascular and metabolic regulation

  2015influential citation
• The Role of NT-Probnp in The Diagnostic Workup of Patient with Chronic Dyspnea of Unexplained Etiology

  2015cites this paper
• Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis

  2015cites this paper
• Evaluation of cardiac sympathetic nerve activity and aldosterone suppression in patients with acute decompensated heart failure on treatment containing intravenous atrial natriuretic peptide

  2014cites this paper
• Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension

  2014influential citation
• Kidney function crucially affects B‐type natriuretic peptide (BNP), N‐terminal proBNP and their relationship

  2014cites this paper
• Left atrial size: an underappreciated perioperative cardiac risk factor.

  2014cites this paper
• Biological, electrical and echocardiographic indices versus cardiac magnetic resonance imaging in diagnosing left ventricular hypertrophy

  2014cites this paper
• Allopurinol regresses left ventricular hypertrophy in patients with type 2 diabetes

  2014cites this paper
• A Functional Genetic Variant (N521D) in Natriuretic Peptide Receptor 3 Is Associated with Diastolic Dysfunction: The Prevalence of Asymptomatic Ventricular Dysfunction Study

  2014cites this paper
• Central pulse pressure links microalbuminuria with plasma B-type natriuretic peptide elevation: causal implication for cardiorenal syndrome in hypertension

  2014cites this paper
• Association of Plasma B-Type Natriuretic Peptide Concentrations With Longitudinal Blood Pressure Tracking in African Americans: Findings From the Jackson Heart Study

  2013cites this paper
• percutaneous cardiopulmonary support Plasma brain natriuretic peptide reflects left ventricular function during

  2013cites this paper
• Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.

  2013cites this paper
• Lack of activation of the antihypertensive cardiac hormones ANP and BNP in human hypertension.

  2013cites this paper
• Efeitos da inibição da fosfodiesterase-5 sobre a disfunção diastólica do ventrículo esquerdo em pacientes com hipertensão arterial resistente

  2013cites this paper
• Association between asleep blood pressure and brain natriuretic peptide during antihypertensive treatment: the Japan Morning Surge-Target Organ Protection (J-TOP) study

  2012cites this paper
• Efficacy and Effect on Plasma B-type Natriuretic Peptide Concentration of Losartan-hydrochlorothiazide for Hypertension Uncontrolled by Losartan-based Therapy: Subanalysis of a Multicentre Prospective Observational Study

  2012cites this paper
• Remodeling of the peripheral cardiac conduction system in response to pressure overload.

  2012influential citation
• Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram.

  2012cites this paper
• Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide Combination and its Effect on Plasma B- Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin II Type 1 Receptor Antagonist-Based Therapy

  2012cites this paper
• N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Predictor of Mortality in Hypertension

  2011cites this paper
• NT-proBNP: a marker of preclinical cardiac damage in arterial hypertension.

  2011cites this paper
• Determinants of plasma brain natriuretic peptide levels in untreated hypertensive patients

  2011cites this paper
• Effect of Valsartan on N-Terminal Pro-Brain Natriuretic Peptide in Patient With Stable Chronic Heart Failure: Comparison With Enalapril

  2011cites this paper
• Brain natriuretic peptide is more than a marker.

  2011cites this paper
• N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension

  2011cites this paper
• PLASMA LEVELS OF NATRIURETIC PEPTIDES AND THEIR CORRELATION WITH ECHOCARDIOGRAPHY AND 24^HOUR BLOOD PRESSURE INDEXES IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC HEART FAILURE

  2011cites this paper
• Synergistic effect of combined HMG-CoA reductase inhibitor and angiotensin-II receptor blocker therapy in patients with chronic heart failure: the HF-COSTAR trial.

  2011cites this paper
• Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population.

  2010cites this paper
• The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension.

  2010cites this paper
• Association of plasma B-type natriuretic peptide levels with obesity in a general urban Japanese population: the Suita Study.

  2010cites this paper
• N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute stroke.

  2010cites this paper
• Pulmonary Hemodynamic Profile and Natriuretic Peptides

  2010cites this paper
• failure and their implications Molecular forms of natriuretic peptides in heart

  2010cites this paper
• N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute stroke Background

  2010cites this paper
• N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General Population

  2010cites this paper
• N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes

  2010cites this paper
• Plasma brain natriuretic peptide at rest and after adenosine-induced myocardial ischemia in normotensive and essential hypertensive patients with suspected coronary artery disease.

  2009cites this paper
• [N-terminal pro-brain natriuretic peptide and cardiac involvement in patients with hypertensive disease].

  2009cites this paper
• Inappropriateness of ventricular hypertrophy is important as a determinant of BNP but not of diastolic filling in untreated hypertensive patients

  2009cites this paper
• Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease.

  2009cites this paper
• Role of natriuretic peptides in cGMP production in fetal cardiac bypass.

  2009cites this paper
• Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study.

  2009cites this paper
• Molecular forms of natriuretic peptides in heart failure and their implications

  2009cites this paper
• Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.

  2009cites this paper
• Journal of Postgraduate Medicine Journal of Postgraduate Medicine in determination of viral etiology in congenital cataract in infants

  2008cites this paper
• Predicting Heart Failure Symptoms by Plasma N-terminal Pro B-Type Natriuretic Peptide for Patients with Chronic Aortic Regurgitation and Preserved Left Ventricular Function

  2008cites this paper
• Sodium, hypertension, and an explanation of the “lag phenomenon” in hemodialysis patients

  2008cites this paper
• Brain natriuretic peptide in women with mild hypertension in perimenopausal period Summary

  2008cites this paper
• Elevated B-Type Natriuretic Peptide Blood Levels during Hypertensive Crisis

  2008cites this paper
• Mózgowy peptyd natriuretyczny u kobiet z łagodnym nadciśnieniem tętniczym w okresie okołomenopauzalnym

  2008cites this paper
• Chronic Actions of a Novel Oral B-Type Natriuretic Peptide Conjugate in Normal Dogs and Acute Actions in Angiotensin II–Mediated Hypertension

  2008cites this paper
• Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis.

  2008cites this paper
• Effetti del training fisico sul rilascio del frammento N-terminale del Brain Natriuretic Peptide (Nt-proBNP) nei pazienti colpiti da infarto miocardico acuto

  2008cites this paper
• N-terminal pro-brain natriuretic peptide--a promising biomarker for the diagnosis of left ventricular hypertrophy in hypertensive women.

  2008cites this paper
• Brain type natriuretic peptide (BNP)—A marker of new millennium in diagnosis of congestive heart failure

  2007cites this paper
• N-terminal probrain natriuretic peptide predicts altered circadian variation in essential hypertension

  2007cites this paper
• The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension

  2007cites this paper
• Doppler-derived indexes and B-type natriuretic peptide in prediction of paroxysmal atrial fibrillation in essential hypertension: a prospective study.

  2007cites this paper
• Brain natriuretic peptide detects cardiac abnormalities in mass screening

  2007cites this paper
• Doppler‐Derived Indexes and B‐Type Natriuretic Peptide in Prediction of Paroxysmal Atrial Fibrillation in Essential Hypertension: A Prospective Study

  2007cites this paper
• N-terminal pro-Brain Natriuretic Peptide plasma levels in healthy subjects and patients with heart diseases

  2007cites this paper
• B-type natriuretic peptide level in the diagnosis of asymptomatic diastolic dysfunction.

  2007cites this paper
• Associations of Plasma Natriuretic Peptide, Adrenomedullin, and Homocysteine Levels With Alterations in Arterial Stiffness: The Framingham Heart Study

  2007cites this paper
• Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease

  2007cites this paper
• Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.

  2007cites this paper
• Plasma brain natriuretic peptide levels indicating thromboembolism in very elderly patients with non-valvular atrial fibrillation.

  2007cites this paper
• Brain natriuretic peptide correlates with troponin T in patients with renal failure

  2007cites this paper
• Additive Effects of Spironolactone and Candesartan on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients with Congestive Heart Failure

  2007cites this paper
• Chapter 31 – Natriuretic Peptides

  2007cites this paper
• B-type natriuretic peptides in heart failure.

  2007cites this paper
• Může závažná esenciální hypertenze způsobit vzestup BNP vedoucí k falešné diagnóze srdečního selhání

  2006cites this paper
• Substantial intraindividual variability of BNP concentrations in patients with hypertension

  2006cites this paper
• Current understanding of biochemical markers in heart failure.

  2006cites this paper
• N-terminal proBrain natriuretic peptide levels predict short-term poststroke survival.

  2006cites this paper
• Prognosis value of atrial natriuretic peptide and brain natriuretic peptide for heart failure in patients undergoing allogeneic bone marrow transplantation

  2006cites this paper
• Chronic Levels Effect of t 9-Adrenoceptor Blockade of Brain Natriuretic Peptide during in Essential Hypertension on Plasma Exercise

  2006cites this paper
• N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy

  2006cites this paper
• Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy.

  2006cites this paper
• Plasma Adrenomedullin Patients with Essential and Natriuretic Peptides in or Malignant Hypertension

  2006cites this paper
• Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration

  2006cites this paper
• The effect of aortic valve replacement on plasma B‐type natriuretic peptide in patients with severe aortic stenosis — one year follow‐up

  2006cites this paper
• Intraindividual temporal variance of biomarkers and the definition of individualized prognosis in cardiovascular patients

  2006cites this paper
• PROGNOSTIC VALUE OF INCREASED PLASMA LEVELS OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH SEPTIC SHOCK

  2006cites this paper
• Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure

  2006cites this paper
• Impaired blood pressure increase in acute cardioembolic stroke

  2006cites this paper